Continental Petroleums Ltd vs Emmessar Biotech Nutrition Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Continental Petroleums Ltd is ₹ 79.71 as of 23 Mar 15:30 . The P/E Ratio of Continental Petroleums Ltd changed from 11.6 on March 2021 to 17.1 on March 2025 . This represents a CAGR of 8.07% over 5 yearsThe P/E Ratio of Emmessar Biotech & Nutrition Ltd changed from 5.1 on March 2021 to 48.2 on March 2025 . This represents a CAGR of 56.71% over 5 years The Market Cap of Continental Petroleums Ltd changed from ₹ 25.77 crore on March 2021 to ₹ 73.62 crore on March 2025 . This represents a CAGR of 23.36% over 5 yearsThe Market Cap of Emmessar Biotech & Nutrition Ltd changed from ₹ 7.35 crore on March 2021 to ₹ 15.2 crore on March 2025 . This represents a CAGR of 15.64% over 5 years The revenue of Continental Petroleums Ltd for the Dec '25 is ₹ 21.01 crore as compare to the Sep '25 revenue of ₹ 24.35 crore. This represent the decline of -13.72% The revenue of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.58 crore as compare to the Sep '25 revenue of ₹ 0.63 crore. This represent the decline of -7.94% The ebitda of Continental Petroleums Ltd for the Dec '25 is ₹ 1.67 crore as compare to the Sep '25 ebitda of ₹ 1.93 crore. This represent the decline of -13.47% The ebitda of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.15 crore as compare to the Sep '25 ebitda of ₹ 0.17 crore. This represent the decline of -11.76% The net profit of Continental Petroleums Ltd changed from ₹ 1.29 crore to ₹ 1.06 crore over 7 quarters. This represents a CAGR of -10.61% The net profit of Emmessar Biotech & Nutrition Ltd changed from ₹ 0.09 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of 17.87% The Dividend Payout of Continental Petroleums Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Emmessar Biotech & Nutrition Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Continental Petroleums Ltd

Continental Petroleums Limited, established in July, 1986 had set up complete plant at Behror, in Rajasthan during the period of 1988-89 to manufacture various kinds of lubricants & greases for Automotive & Industrial application.
The Company is one of the leading manufacturers of industrial lubricants in India and manufacturing wide range of premium quality lubricants for Automotive & Industrial Application, specialties and process oils etc. under the brand name of 'CONTOL'.
It is also engaged in Common Treatment Disposal / Incineration of hazardous waste viz. solid, Liquid and Aqueous received from various industries. The Plant is spread over 20000 sq. meter with sufficient scope for expansion and processing and blending, R&D facilities with capacity of 9000 KL / Annum as per DGTD registration.

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
The Company has so far, succeeded in developing many Specialty Fine Chemicals.
ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

FAQs for the comparison of Continental Petroleums Ltd and Emmessar Biotech & Nutrition Ltd

Which company has a larger market capitalization, Continental Petroleums Ltd or Emmessar Biotech & Nutrition Ltd?

Market cap of Continental Petroleums Ltd is 81 Cr while Market cap of Emmessar Biotech & Nutrition Ltd is 12 Cr

What are the key factors driving the stock performance of Continental Petroleums Ltd and Emmessar Biotech & Nutrition Ltd?

The stock performance of Continental Petroleums Ltd and Emmessar Biotech & Nutrition Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Continental Petroleums Ltd and Emmessar Biotech & Nutrition Ltd?

As of March 23, 2026, the Continental Petroleums Ltd stock price is INR ₹86.28. On the other hand, Emmessar Biotech & Nutrition Ltd stock price is INR ₹24.34.

How do dividend payouts of Continental Petroleums Ltd and Emmessar Biotech & Nutrition Ltd compare?

To compare the dividend payouts of Continental Petroleums Ltd and Emmessar Biotech & Nutrition Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.